dc.contributor.author | Tutar, Yusuf | |
dc.date.accessioned | 2019-07-27T12:10:23Z | |
dc.date.accessioned | 2019-07-28T10:13:47Z | |
dc.date.available | 2019-07-27T12:10:23Z | |
dc.date.available | 2019-07-28T10:13:47Z | |
dc.date.issued | 2010 | |
dc.identifier.issn | 1389-2010 | |
dc.identifier.uri | https://dx.doi.org/10.2174/138920110790909722 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/9931 | |
dc.description | WOS: 000275517100001 | en_US |
dc.description | PubMed ID: 20230365 | en_US |
dc.description.abstract | … | en_US |
dc.language.iso | eng | en_US |
dc.publisher | BENTHAM SCIENCE PUBL LTD | en_US |
dc.relation.isversionof | 10.2174/138920110790909722 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Therapeutic Use of Heat Shock Proteins and Essential Factors in Prognosis, Diagnosis and Treatment of Neurodegenerative and Metabolic Diseases | en_US |
dc.type | other | en_US |
dc.relation.journal | CURRENT PHARMACEUTICAL BIOTECHNOLOGY | en_US |
dc.contributor.department | Cumhuriyet Univ, Fac Med, Div Biochem, TR-58140 Sivas, Turkey | en_US |
dc.identifier.volume | 11 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.endpage | 138 | en_US |
dc.identifier.startpage | 138 | en_US |
dc.relation.publicationcategory | Diğer | en_US |